Aehr Test Systems, Inc. designs and manufactures advanced test and burn-in equipment for semiconductor devices. The company specializes in wafer-level testing for high-power applications, including silicon carbide (SiC) and gallium nitride (GaN) power semiconductors, as well as AI processors and photonics. At the core of its business is the FOX family of systems, such as FOX-XP and FOX-NP, which enable full-wafer contact testing and stabilization for next-generation chips used in data centers, electric vehicles, and mobile devices.
In the competitive semiconductor equipment industry, Aehr maintains niche leadership in burn-in testing for emerging technologies—particularly those vital to AI acceleration and power efficiency. From what I see, this positioning has played a key role in the recent stock strength, as growing demand for AI infrastructure opens up high-growth markets led by hyperscale cloud providers.
In the last 30 days, AEHR stock climbed from a closing price of about $37.09 to $74.38, delivering a +101% gain. The path was volatile and trend-driven, with sharp accelerations after major announcements, including several days of double-digit jumps.
Over the past quarter, shares rose +158% from around $28.81. This reflected a steady climb with momentum bursts linked to AI developments. The stock traded in a range early on before breaking out on positive news, handily beating broader market indices. I also looked at this through Tickeron’s AI Screener to gauge how it stacks up against peers.
The main spark came from Aehr's fiscal third-quarter earnings on April 7, 2026, reporting an adjusted loss of $0.05 per share—better than the consensus -$0.07—paired with $10.3 million in revenue. Even with the loss, the market latched onto over $37 million in quarterly bookings from AI and data center demand, lifting second-half bookings above $92 million. That sparked a 59% jump right after.
Follow-on news included a record $41 million production order from a leading hyperscale AI customer for FOX-XP systems, plus a previous $14 million order from the same area. These highlight strong demand for Aehr's wafer-level burn-in solutions in AI processors. Technical positives like a golden cross, alongside semiconductor sector momentum, drove shares to all-time highs.
The quarter's advance was rooted in ongoing AI data center expansion, with Aehr gaining from wider use of its systems to test high-power semiconductors crucial for AI setups. Fiscal second-quarter results in January offered better visibility into AI processor demand, restoring revenue guidance despite softer sales.
Macro factors, such as hyperscalers' rising capex on AI hardware and a semiconductor rebound after the downturn, added fuel. Institutional buying and sector lifts from names like Nvidia and Broadcom helped too. Aehr's edge in SiC and GaN testing positions it well for data center power needs, with order wins making the biggest difference.
In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights top-performing AI-driven trading bots from a library of hundreds. These bots trade thousands of tickers across markets, selected by recent performance, market relevance, and strategies like momentum, mean reversion, and pattern recognition for short-term, swing, or long-term plays. While past performance isn't a promise of future results, it gives clear views into live activity, backtests, and win rates. It's a practical way to explore automated approaches that could suit stocks like AEHR.
One thing I’m watching closely is the fiscal fourth-quarter earnings for updates on second-half revenue guidance ($25-30 million) and more AI bookings. Ongoing orders from hyperscalers and pushes into power semiconductors will matter. Keep an eye on AI infrastructure spending, supply chain shifts, and macro elements like interest rates affecting capex. Risks involve turning backlog into revenue and competition, but upsides could come from new wins in photonics or SiC testing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
AEHR saw its Momentum Indicator move below the 0 level on June 26, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In of the 83 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on June 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
AEHR moved below its 50-day moving average on June 26, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 251 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 47, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.707) is normal, around the industry mean (12.514). P/E Ratio (19.449) is within average values for comparable stocks, (117.123). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.237). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (75.758) is also within normal values, averaging (128.191).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment